UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED CONDENSED STATEMENT OF CASH FLOW - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 3,139	$ 4,092
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation	179	200
Amortization	1,271	570
Provision for (recovery of) losses on accounts receivable	0	1
Amortization of Right of Use Assets	10	0
Deferred income taxes	(142)	(76)
Stock-based compensation expense	28	30
Tax benefit attributable to exercise of stock options	13	16
Changes in operating assets and liabilities:
Accounts receivable and other receivables	(940)	(560)
Inventories	(2,255)	(303)
Prepaid expenses and other current assets	(23)	(53)
Accounts payable	1,868	142
Accrued expenses	212	(293)
Total adjustments	221	(326)
Net cash provided by operating activities	3,360	3,766
CASH FLOWS FROM INVESTING ACTIVITIES:
Property and equipment	(12)	(173)
Intangible assets	(21,000)	0
Net cash provided by (used in) investing activities	(21,012)	(173)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock - options	97	147
Payment of dividends	(1,027)	(1,005)
Net cash provided by (used in) financing activities	(930)	(858)
Effect of exchange rate changes on cash	135	243
Net increase (decrease) in cash and cash equivalents	(18,447)	2,978
Cash at beginning of period	51,112	39,875
Cash at end of period	32,665	42,853
Cash paid during the period for income taxes	406	788
Cash paid during the period for interest	$ 0	$ 0